What type of study is this?

This is a Network Pharmacology study (also classified as: Bioinformatics, Molecular Docking).

September 10, 2025MedicineOpen Access

Integrating network pharmacology, bioinformatics and molecular docking to explore the anti-NSCLC mechanisms of EGCG in green tea

View Full Paper

Ask AI

Bookmark

EGCG demonstrates significant anti-NSCLC effects via multi-target interactions and pathway modulation.
224 NSCLC-related targets were identified through network pharmacology, highlighting key hubs like TP53 and AKT1.
Molecular docking analysis confirmed strong binding affinities between EGCG and its target proteins.
Insights into oxidative stress regulation indicate novel therapeutic strategies for treating non-small cell lung cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

An integrative analysis unveils EGCG's potential against non-small cell lung cancer, suggesting critical mechanisms like PI3K/Akt pathway modulation and oxidative stress regulation.

Cite This Study

Yang et al. (2025) studied this question.

synapsesocial.com/papers/68c1955c9b7b07f3a061940e https://doi.org/10.1097/md.0000000000044070

View Full Paper

Ask AI

Bookmark

Implication

An integrative analysis unveils EGCG's potential against non-small cell lung cancer, suggesting critical mechanisms like PI3K/Akt pathway modulation and oxidative stress regulation.

Integrating network pharmacology, bioinformatics and molecular docking to explore the anti-NSCLC mechanisms of EGCG in green tea

Key Points

Discussion

Implication

Cite This Study

Integrating network pharmacology, bioinformatics and molecular docking to explore the anti-NSCLC mechanisms of EGCG in green tea

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider